Blog – Katalyst Wealth

[Stock idea]: Krsnaa Diagnostics – This diagnostics company prices 90% below the market. How?

September 8, 2026

Krsnaa Diagnostics just posted 22% revenue growth. Its stock-friendly narrative talks about “purpose” and “Bharat Ka Bharosemand Diagnostics.” Here’s what the transcript and presentation actually show, and the questions we’d still want answered before treating this quarter as a green light, but before that: Spread the Word: If you think our stock recommendations could add value to your friends, relatives, or acquaintances, we’d appreciate you spreading the word about Katalyst Wealth. Latest Stock recommendations under Alpha, Alpha +, and Insider Bets…

[Stock idea]: National Fittings: record revenue, 86% jump in core profit, and a promoter change

September 3, 2026

National Fittings Limited just closed out FY26 with its highest-ever annual revenue — and in the same year, its founding promoter sold out entirely to a new group with four decades in the castings business. That’s not a coincidence of timing. The annual report lays out a company mid-transition, with a capacity expansion plan that’s genuinely outsized relative to its current scale. Here are the notes from National Fittings’ FY26 Annual Report:, but before that: Spread the Word: If you think…

New Alpha/Alpha + Stock dropping in 1 day: A hidden gem transforming from B2B to B2C

August 30, 2026

A quick heads-up — we’re about to release a new stock recommendation for (opens in new tab)Alpha/Alpha + members in the next 1 day. Without revealing the name, here’s why we think this is worth your attention: A 30+ year legacy business that most investors have probably never looked at closely A founder-led company quietly transforming from a pure B2B supplier into a fast-scaling consumer-facing retail brand Revenue and profit have compounded at ~30% and ~35% respectively over the last 3 years,…

[Stock idea]: Kuantum Paper – Valuations approaching Covid-19 lows

August 27, 2026

Companies making paper have gone through tough times in the last few years. On one end they had to deal with higher raw material prices and on the other hand lower finished goods prices. The profits are tending towards cyclical lows and similarly the valuations on metrics like Price to book value and market cap to sales are also closer to covid-19 lows. Here are the notes from Kuantum’s Q1 FY27 earnings call and investor presentation, but before that: Spread…